707 related articles for article (PubMed ID: 19839712)
41. Formulation and evaluation of Nimodipine-loaded solid lipid nanoparticles delivered via lymphatic transport system.
Chalikwar SS; Belgamwar VS; Talele VR; Surana SJ; Patil MU
Colloids Surf B Biointerfaces; 2012 Sep; 97():109-16. PubMed ID: 22609590
[TBL] [Abstract][Full Text] [Related]
42. Development of novel polymer-stabilized diosmin nanosuspensions: in vitro appraisal and ex vivo permeation.
Freag MS; Elnaggar YS; Abdallah OY
Int J Pharm; 2013 Sep; 454(1):462-71. PubMed ID: 23830765
[TBL] [Abstract][Full Text] [Related]
43. Brain delivery of camptothecin by means of solid lipid nanoparticles: formulation design, in vitro and in vivo studies.
Martins S; Tho I; Reimold I; Fricker G; Souto E; Ferreira D; Brandl M
Int J Pharm; 2012 Dec; 439(1-2):49-62. PubMed ID: 23046667
[TBL] [Abstract][Full Text] [Related]
44. Development of gatifloxacin-loaded cationic polymeric nanoparticles for ocular drug delivery.
Duxfield L; Sultana R; Wang R; Englebretsen V; Deo S; Swift S; Rupenthal I; Al-Kassas R
Pharm Dev Technol; 2016 Mar; 21(2):172-9. PubMed ID: 26794936
[TBL] [Abstract][Full Text] [Related]
45. Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
Silva AC; Kumar A; Wild W; Ferreira D; Santos D; Forbes B
Int J Pharm; 2012 Oct; 436(1-2):798-805. PubMed ID: 22867992
[TBL] [Abstract][Full Text] [Related]
46. Studies on binary lipid matrix based solid lipid nanoparticles of repaglinide: in vitro and in vivo evaluation.
Rawat MK; Jain A; Singh S
J Pharm Sci; 2011 Jun; 100(6):2366-78. PubMed ID: 21491449
[TBL] [Abstract][Full Text] [Related]
47. Re-dispersible cationic solid lipid nanoparticles (SLNs) freeze-dried without cryoprotectors: characterization and ability to bind the pEGFP-plasmid.
Vighi E; Ruozi B; Montanari M; Battini R; Leo E
Eur J Pharm Biopharm; 2007 Sep; 67(2):320-8. PubMed ID: 17368876
[TBL] [Abstract][Full Text] [Related]
48. Solid lipid nanoparticles (SLN) of tretinoin: potential in topical delivery.
Shah KA; Date AA; Joshi MD; Patravale VB
Int J Pharm; 2007 Dec; 345(1-2):163-71. PubMed ID: 17644288
[TBL] [Abstract][Full Text] [Related]
49. Formulation and evaluation of metoclopramide solid lipid nanoparticles for rectal suppository.
Mohamed RA; Abass HA; Attia MA; Heikal OA
J Pharm Pharmacol; 2013 Nov; 65(11):1607-21. PubMed ID: 24102470
[TBL] [Abstract][Full Text] [Related]
50. Preparation, optimization, and
Nasiri F; Faghfouri L; Hamidi M
Drug Dev Ind Pharm; 2020 Jan; 46(1):159-171. PubMed ID: 31894713
[No Abstract] [Full Text] [Related]
51. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
[TBL] [Abstract][Full Text] [Related]
52. Self-reporter shikonin-Act-loaded solid lipid nanoparticle: formulation, physicochemical characterization and geno/cytotoxicity evaluation.
Eskandani M; Nazemiyeh H
Eur J Pharm Sci; 2014 Aug; 59():49-57. PubMed ID: 24768857
[TBL] [Abstract][Full Text] [Related]
53. Novel dual-reverse thermosensitive solid lipid nanoparticle-loaded hydrogel for rectal administration of flurbiprofen with improved bioavailability and reduced initial burst effect.
Din FU; Mustapha O; Kim DW; Rashid R; Park JH; Choi JY; Ku SK; Yong CS; Kim JO; Choi HG
Eur J Pharm Biopharm; 2015 Aug; 94():64-72. PubMed ID: 25979136
[TBL] [Abstract][Full Text] [Related]
54. Influence of surfactants on the physical stability of solid lipid nanoparticle (SLN) formulations.
Uner M; Wissing SA; Yener G; Müller RH
Pharmazie; 2004 Apr; 59(4):331-2. PubMed ID: 15125588
[TBL] [Abstract][Full Text] [Related]
55. Cationic solid lipid nanoparticles (cSLN): structure, stability and DNA binding capacity correlation studies.
Doktorovova S; Shegokar R; Rakovsky E; Gonzalez-Mira E; Lopes CM; Silva AM; Martins-Lopes P; Muller RH; Souto EB
Int J Pharm; 2011 Nov; 420(2):341-9. PubMed ID: 21907778
[TBL] [Abstract][Full Text] [Related]
56. Topical gel of Metformin solid lipid nanoparticles: A hopeful promise as a dermal delivery system.
Rostamkalaei SS; Akbari J; Saeedi M; Morteza-Semnani K; Nokhodchi A
Colloids Surf B Biointerfaces; 2019 Mar; 175():150-157. PubMed ID: 30530000
[TBL] [Abstract][Full Text] [Related]
57. [Preparation of solid lipid nanoparticles loaded with all-trans retinoic acid and their evaluation in vitro and in vivo].
Hu LD; Tang X; Cui FD
Yao Xue Xue Bao; 2005 Jan; 40(1):71-5. PubMed ID: 15881775
[TBL] [Abstract][Full Text] [Related]
58. Preparation, optimization, characterization and in vivo pharmacokinetic study of asiatic acid tromethamine salt-loaded solid lipid nanoparticles.
Lingling G; Yuan Z; Weigen L
Drug Dev Ind Pharm; 2016 Aug; 42(8):1325-33. PubMed ID: 26821124
[TBL] [Abstract][Full Text] [Related]
59. Solid lipid nanoparticles (SLN)--based hydrogels as potential carriers for oral transmucosal delivery of risperidone: preparation and characterization studies.
Silva AC; Amaral MH; González-Mira E; Santos D; Ferreira D
Colloids Surf B Biointerfaces; 2012 May; 93():241-8. PubMed ID: 22293602
[TBL] [Abstract][Full Text] [Related]
60. Design and evaluation of polymer coated carvedilol loaded solid lipid nanoparticles to improve the oral bioavailability: a novel strategy to avoid intraduodenal administration.
Venishetty VK; Chede R; Komuravelli R; Adepu L; Sistla R; Diwan PV
Colloids Surf B Biointerfaces; 2012 Jun; 95():1-9. PubMed ID: 22463845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
